English | Español

Biospace
Patient Daily | Feb 5, 2026

Biopharma employers show increased willingness toward hiring remote workers
Patient Daily | Feb 5, 2026

Regulatory professionals address challenges from new FDA guidance and evolving technology
Patient Daily | Feb 5, 2026

Merck ends talks with Revolution Medicines over acquisition price disagreement
Patient Daily | Feb 5, 2026

Sarepta reports sustained benefit from DMD gene therapy three years after treatment
Patient Daily | Feb 5, 2026

Corcept reports positive Phase III results for ovarian cancer drug relacorilant
Patient Daily | Feb 5, 2026

Sandbox approach proposed as new model for rare disease drug development
Patient Daily | Feb 5, 2026

Revolution Medicines remains independent after failed takeover talks with Merck
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial

Trending
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Regulatory
Patient Daily | Mar 9, 2026

Pharmacy owner Kiefer on PBMs: 'Independent pharmacies are being aggressively pushed out of business by the monopolistic practices of PBMs'
+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research